Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Sorrento Therapeutics, Inc. Investors (SRNE)


Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf
of Sorrento Therapeutics, Inc. (NASDAQ: SRNE)
investors concerning the Company and its directors' and officers'
possible violations of state laws.

If you purchased Sorrento Therapeutics stock, have information, or would
like to learn more about these claims, or have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Lesley Portnoy, of GPM, 1925 Century Park East,
Suite 2100, Los Angeles, CA 90067 at 310-201-9150, Toll-Free at
888-773-9244, or Bryan Faubus, of GPM, 230 Park Avenue, Suite 530, New
York, NY 10169 at 212-682-5340 or at,
or visit our website at
If you inquire by email please include your mailing address, telephone
number, and the number of shares purchased.

This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial